This content is machine translated Type 2 diabetes: PIONEER REAL Switzerland study Semaglutide in oral form convinces in everyday practice In the non-interventional PIONEER REAL Switzerland study, adult type 2 diabetics treated with oral semaglutide as part of routine clinical care achieved clinically significant improvement in glycemic control with no…
